{"DataElement":{"publicId":"6001038","version":"1","preferredName":"Clinical Study Protocol Disease or Disorder Assessment Timepoint Identifier","preferredDefinition":"One or more characters used to identify, name, or characterize the protocol point in time for the assessment of disease.","longName":"PROT_DZ_TPT_ID","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6001025","version":"1","preferredName":"Clinical Study Protocol Disease or Disorder Assessment Timepoint","preferredDefinition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the trial, but these could be represented in other protocol referenced documents._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The final result of a determination of the value, significance, or extent of._A specific point in the time continuum, including those established relative to an event.","longName":"2480914v1.0:2826784v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2480914","version":"1","preferredName":"Protocol Diseases and Disorders","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C25320:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"135CC719-B0D9-1DFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-05-09","modifiedBy":"ONEDATA","dateModified":"2006-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2826784","version":"1","preferredName":"Assessment Timepoint","preferredDefinition":"Having determined the value, significance, or extent of.:A specific point in the time continuum, including those established relative to an event.","longName":"C25217:C68568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"609E58D8-0EDD-8A7B-E040-BB89AD430D0D","latestVersionIndicator":"Yes","beginDate":"2009-01-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2009-01-16","modifiedBy":"ONEDATA","dateModified":"2009-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B374678-B21B-15D5-E053-F662850AA246","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"TAYLORT","dateModified":"2017-10-17","changeDescription":"10/17/17 tt approved and released/PC. 10/10/2017 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6001027","version":"1","preferredName":"Timepoint Identifier","preferredDefinition":"A specific point in the time continuum, including those established relative to an event._One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"6001027v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Baseline","valueDescription":"Baseline (within 1 week of first dose)","ValueMeaning":{"publicId":"6001028","version":"1","preferredName":"Baseline (within 1 week of first dose)","longName":"6001028","preferredDefinition":"Baseline (within 1 week of first dose)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B37785A-7532-6D43-E053-F662850ACE13","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B37785A-754B-6D43-E053-F662850ACE13","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"ONEDATA","dateModified":"2017-10-10","deletedIndicator":"No"},{"value":"Every 4 weeks","valueDescription":"Every 4 weeks (following initial documentation of objective response)","ValueMeaning":{"publicId":"6001029","version":"1","preferredName":"Every 4 weeks (following initial documentation of objective response)","longName":"6001029","preferredDefinition":"Every 4 weeks (following initial documentation of objective response)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B37785A-7555-6D43-E053-F662850ACE13","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B37785A-756E-6D43-E053-F662850ACE13","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"ONEDATA","dateModified":"2017-10-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6001085","version":"1","preferredName":"Timepoint Identifier","preferredDefinition":"A specific point in the time continuum, including those established relative to an event.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C68568:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B382944-CA88-0B64-E053-F662850AE70B","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"ONEDATA","dateModified":"2017-10-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B37785A-751D-6D43-E053-F662850ACE13","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"TAYLORT","dateModified":"2017-10-17","changeDescription":"10/17/17 tt approved and released/PC.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Myeloma assessment timepoint","type":"Preferred Question Text","description":"Myeloma assessment timepoint","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B379B02-63A2-054A-E053-F662850A3496","latestVersionIndicator":"Yes","beginDate":"2017-10-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-10","modifiedBy":"TAYLORT","dateModified":"2017-10-17","changeDescription":"10/17/17 tt approved and released/PC. 10/10/17 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}